Deborah Morosini Net Worth & Insider Trades

Deborah Morosini - EVP, Prelude Therapeutics Inc

As of February 17, 2022

What is Deborah Morosini's Net Worth?

The current estimated net worth of Prelude Therapeutics Inc's EVP, Deborah Morosini, is estimated to be about $1.01M . Deborah Morosini owns about 444 units of Prelude Therapeutics Inc common stock. In the last 2 years at Prelude Therapeutics Inc, Deborah Morosini has sold an estimated value of $1M worth.

What is Deborah Morosini's Past Insider Trading?

Deborah Morosini's largest purchase order was 28,751 units , worth over $369.45K on November 18, 2021. Deborah Morosini's largest sale order was 28,751 units , worth over $456.53K on November 18, 2021. In total, Deborah Morosini has made about 8 transactions over 2 years of their time at Prelude Therapeutics Inc. Deborah Morosini usually trades in April, with the busiest year in 2021. The most recent transaction was a sale order of 28,751 units , worth over $373.76K on December 17, 2021.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Deborah Morosini

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Deborah Morosini's' Mailing Address?

  • Mailing address is C/o Prelude Therapeutics Incorporated 200 Powder Mill Road Wilmington DE 19803 DE

What are Prelude Therapeutics Inc's Past Insider Trades?

Prelude Therapeutics Inc's most recent insider trade came on May 26, 2023 by Krishna Vaddi who bought 1,900 units worth $9.79K . In the last 3 years, insiders at Prelude Therapeutics Inc have sold an estimated value of $10.41M and bought an estimated value of $89.47M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are David Mauro, Chief Medical Officer,  Laurent Chardonnet, Chief Financial Officer,  and Peggy Scherle, Chief Scientific Officer .

Prelude Therapeutics Inc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...